Post-approval studies (Phase 4)Study completedNCT00502138
What this trial is testing
A Pilot Study of Continuous Subcutaneous Pramlintide Infusion Therapy in Patients With Type 1 Diabetes
Who this might be right for
IDDM
University Diabetes & Endocrine Consultants 12